Early identification of high-risk individuals for monoclonal antibody therapy and prophylaxis is feasible by SARS-CoV-2 anti-spike antibody specific lateral flow assay

Autor: Pallett, Scott J.C., Rayment, Michael, Heskin, Joseph, Mazzella, Andrea, Jones, Rachael, Mughal, Nabeela, Randell, Paul, Davies, Gary W., Moore, Luke S.P.
Zdroj: In Diagnostic Microbiology & Infectious Disease November 2022 104(3)
Databáze: ScienceDirect
Externí odkaz: